• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Planning for proactive pharmacovigilance

Planning for proactive pharmacovigilance

September 1, 2017
CenterWatch Staff

The role of pharmacovigilance is becoming increasingly prominent, with scope to inform product strategy and health economics. A recent industry debate hosted by ProductLife Group saw some interesting tips for clinical operations.

Look beyond the regulatory burden.

Keeping the higher purpose—patient safety—in focus can help with prioritization, as can identifying ways to benefit operationally and commercially from the rich knowledge base you’re building.

Facilitate cross-functional collaboration.

Pharmacovigilance requires input from throughout the organization, including from affiliates, so it’s important to standardize and align business processes.

Apply pharmacovigilance to inform strategic decisions.

The more complete and the more reliable the picture that pharmacovigilance is developing, the greater the value to the business. A clearer view of safety can influence the decision regarding whether a company should proceed with, say, acquisitions based on products’ risk–benefit profile. As a result, pharmacovigilance could, in the future, play a more active role during the due diligence process.

Look to safety as a competitive advantage.

We can expect to see enhanced safety position itself as a competitive differentiator. Clinical teams can play a proactive role here by highlighting a brand’s properties as part of the clinical development plan.

Rethink roles and skills.

As pharmacovigilance’s reach lengthens, companies will consider whether the function has the sufficient business and strategic skills and experience needed to exert greater influence in clinical risk–benefit and health economics decision making and to play a more integral role in R&D.

 

Guest Contributor Cheryl Key, MBBS, MFPM, is head of practice PV platform services/principal medic at ProductLife Group, with final responsibility for all projects, programmes, and engagements in the platform, as well as for day-to-day management of the platform team.

Cheryl has more than 15 years of drug safety experience in working with pharmaceutical and biotech companies, contract research organizations, and regulatory authorities. She guides her team to improve and optimise ways of working, to achieve high performance levels, to establish continuous improvement in consistent platform processes, and to ensure compliance by all platform staff with legal, regulatory, and quality requirements. Before joining the pharmaceutical industry, Cheryl spent several years in medical practice in hospital and primary care.

This article was reprinted from Volume 24, Issue 09, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing